Literature DB >> 26770573

XRCC1 Arg194Trp and Arg399Gln polymorphisms and risk of extrahepatic cholangiocarcinoma: a hospital-based case-control study in China.

Yuanfeng Gong1, Ming Qi2, Jun Chen1, Runya Fang1, Cong Mai1, Tiejun Chen1, Hui Tang1, Yunqiang Tang1.   

Abstract

BACKGROUND: Extrahepatic cholangiocarcinoma (ECCA) is a rare but devastating malignancy. Up to 90% of patients presenting with ECCA have no identifiable risk factors. The base excision repair (BER) pathway has a principal role in the repair of mutations caused by oxidized or reduced bases. The XRCC1 is one of the key proteins in the BER pathway. In this study, we investigated the influence of XRCC1 Arg194Trp and Arg399Gln polymorphisms on ECCA incidence.
METHODS: The study included 189 ECCA patients and 216 controls. Genotypes were detected by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) method.
RESULTS: For codon 194, the genotype frequencies of C/C, T/C and T/T were 51.3, 43.4 and 5.3%, respectively, in the ECCA cases compared with 54.2, 38.9 and 6.9%, respectively, in the controls. No statistically significant differences were observed in the genotype frequencies of codon 194 between the two groups compared to the control (TC, OR: 0.85, 95% CI: 0.57-1.28, TT, OR: 1.24, 95% CI: 0.54-2.89, TC+TT, OR: 0.89, 95% CI: 0.60-1.32). For codon 399, the genotype frequencies of G/G, G/A and A/A were 54.0, 37.0 and 9.0%, respectively, in the ECCA cases compared with 56.1, 39.8 and 4.1%, respectively, in the controls. No statistically significant differences were observed in the genotype frequencies codon 399 between the two groups compared to the control (GA, OR: 1.04, 95% CI: 0.69-1.56, AA, OR: 0.45, 95% CI: 0.19-1.04, GA+AA, OR: 0.92, 95% CI: 0.62-1.36). Meanwhile, no statistically significant differences were found in the haplotype and risk of developing ECCA compared to the control (CA, OR: 0.83, 95% CI: 0.49-1.39, TG, OR: 0.96, 95% CI: 0.58-1.60, TA, OR: 0.83, 95% CI: 0.38-1.82).
CONCLUSION: The present study suggested that Arg194Trp and Arg399Gln polymorphism in the DNA repair gene XRCC1 was not statistically associated with risk of ECCA. It would be necessary to confirm these findings in a large sample size and multiethnic population study in future.

Entities:  

Keywords:  XRCC1; cholangiocarcinoma; polymorphism; risk; susceptibility

Year:  2015        PMID: 26770573      PMCID: PMC4694473     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  27 in total

1.  XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency.

Authors:  R M Lunn; R G Langlois; L L Hsieh; C L Thompson; D A Bell
Journal:  Cancer Res       Date:  1999-06-01       Impact factor: 12.701

2.  Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.

Authors:  W R Jarnagin; Y Fong; R P DeMatteo; M Gonen; E C Burke; J Bodniewicz BS; M Youssef BA; D Klimstra; L H Blumgart
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

3.  Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China.

Authors:  Wen-Yi Huang; Yu-Tang Gao; Asif Rashid; Lori C Sakoda; Jie Deng; Ming-Chang Shen; Bin-Sheng Wang; Tian-Quan Han; Bai-He Zhang; Bingshu E Chen; Philip S Rosenberg; Stephen J Chanock; Ann W Hsing
Journal:  Carcinogenesis       Date:  2007-11-04       Impact factor: 4.944

4.  Polymorphisms in the XRCC1 gene are associated with treatment response to platinum chemotherapy in advanced non-small cell lung cancer patients based on meta-analysis.

Authors:  L Li; C Wan; F Q Wen
Journal:  Genet Mol Res       Date:  2014-05-16

5.  An updated meta-analysis on the association of X-ray repair cross complementing group 1 codon 399 polymorphism with hepatocellular carcinoma risk.

Authors:  Ya-Dong Wang; Wen-Long Zhai; Hai-Yu Wang; Xiang-Qun Xia
Journal:  Asian Pac J Cancer Prev       Date:  2014

6.  Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in North Indian population.

Authors:  Anvesha Srivastava; Kshitij Srivastava; Sachchida Nand Pandey; G Choudhuri; B Mittal
Journal:  Ann Surg Oncol       Date:  2009-03-06       Impact factor: 5.344

7.  XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis.

Authors:  Yongsheng Huang; Linguo Li; Long Yu
Journal:  Mutagenesis       Date:  2009-05-22       Impact factor: 3.000

8.  Gallbladder cancer predisposition: a multigenic approach to DNA-repair, apoptotic and inflammatory pathway genes.

Authors:  Kshitij Srivastava; Anvesha Srivastava; Ashok Kumar; Balraj Mittal
Journal:  PLoS One       Date:  2011-01-21       Impact factor: 3.240

9.  Gene-environment interaction involved in cholangiocarcinoma in the Thai population: polymorphisms of DNA repair genes, smoking and use of alcohol.

Authors:  Nopparat Songserm; Supannee Promthet; Chamsai Pientong; Tipaya Ekalaksananan; Peechanika Chopjitt; Surapon Wiangnon
Journal:  BMJ Open       Date:  2014-10-21       Impact factor: 2.692

Review 10.  Genomic instability and the selection of treatments for cancer.

Authors:  Sarah A Martin; Madeleine Hewish; Christopher J Lord; Alan Ashworth
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.